Td Waterhouse Canada Inc. Dexcom Inc Transaction History

Td Waterhouse Canada Inc.

$12.3 Trillion
Q3 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 154 shares of DXCM stock, worth $12,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154

Previous 694 77.81%

Holding current value

$12,326

Previous $77.8 Million 86.95%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $34,560 - $62,672	-540 Reduced 77.81%	154 $10.2 Million
Q2 2024 Nov 12, 2024	BUY	$110.31 - $140.45 $3,088 - $3,932	28 Added 4.2%	694 $77.8 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $2.27 Million - $2.78 Million	-19,869 Reduced 96.76%	666 $92.7 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $659,329 - $1.08 Million	-8,734 Reduced 29.84%	20,535 $3.31 Billion
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $1.44 Million - $2.3 Million	-16,683 Reduced 36.31%	29,269 $3.74 Billion
Q2 2023 Nov 13, 2023	BUY	$112.47 - $130.98 $4.3 Million - $5.01 Million	38,257 Added 497.17%	45,952 $7.56 Billion
Q1 2023 Nov 13, 2023	SELL	$104.0 - $122.92 $1.88 Million - $2.23 Million	-18,113 Reduced 70.18%	7,695 $964 Million
Q4 2022 Nov 13, 2023	BUY	$84.98 - $122.67 $2.15 Million - $3.11 Million	25,344 Added 5462.07%	25,808 $3.55 Billion
Q2 2022 Nov 13, 2023	BUY	$67.99 - $132.89 $23,048 - $45,049	339 Added 271.2%	464 $36 Million
Q1 2022 Nov 13, 2023	SELL	$94.08 - $130.2 $94 - $130	-1 Reduced 0.79%	125 $67 Million
Q4 2021 Nov 13, 2023	BUY	$129.87 - $162.82 $16,363 - $20,515	126 New	126 $64.8 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Dexcom Inc Transaction History